ClinicalTrialsFinder
CompletedPhase 4ACTRN12608000559314

Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Sertraline) - Pilot study.

Sponsor

NSW Justice Health

Enrollment

20 participants

Start Date

Dec 1, 2007

Study Type

Interventional

Conditions

Impulsivity Violence

Summary

To determine whether SSRI are effective in reducing impulsive behaviour in repeat violent offenders.

Eligibility

Sex: MalesMin Age: 18 Yearss

Inclusion Criteria3

  • Men
  • At least 1 prior conviction for violence
  • Score over 70 on an impulsivity screener

Exclusion Criteria6

  • Current medications include a Selective Serotonin Reuptake Inhibitor (SSRI) or other antidepressant (especially a Mono Amine Oxidase Inhibitor) or anti-psychotics.
  • Severe mental illness.
  • History of adverse drug reactions to a Selective Serotonin Reuptake Inhibitor (SSRI).
  • Past conviction for murder, manslaughter or sexual assault.
  • Regular use of amphetamine.
  • From remote/inaccessible area.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Oral Selective Serotonin Reuptake Inhibitor 100mg daily for 3 months.

Oral Selective Serotonin Reuptake Inhibitor 100mg daily for 3 months.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000559314